Market by Drug Class, Application, and Country | Forecast 2019-2028
Triton Market Research predicts that the global market for dermatological therapeutics would witness a CAGR of 7.90% over the forecast period 2019-2028. The market was assessed to be worth $24.69 billion in the year 2019, and is predicted to generate a revenue of approximately $48.94 million by the year 2028.
Report scope can be customized per your requirements. Request For Customization
Dermatological therapeutics has witnessed stable growth owing to the rising burden of dermatological diseases. Dermatological therapeutics deals with the treatment and prevention of the diseases of the skin, hairs, nails, genitals, and oral cavities.
Triton Market
Research’s report on the dietary supplements market provides an in-depth
insight into the market. The detailed analysis of the market includes key
market insights, Porter’s five forces analysis, and market attractiveness
index.
Key drivers such as the
rise in skin diseases and increasing awareness towards disease prognosis are
fueling the market demand. According to the Global Burden of Disease (GBD),
acne vulgaris affects about 84% of adolescents aged between 12–25 years. Acne
consistently represents the topmost prevalent skin conditions in the general
population, as found in large studies within the United Kingdom, France, and
the United States. In recent years, due to a better understanding of the
pathogenesis of acne and other therapeutics, the market is gaining traction.
Moreover, in developing
countries such as India, several studies have been published on skin diseases
that showcase that the rising skin diseases in the rural sector, paired with
the low level of sanitation, is among the primary reasons for the large number
of skin diseases prevalent today, such as seborrhea capitis, acne vulgaris,
tinea, pityriasis versicolor, and scabies. Such factors are propelling the
growth of the overall market.
However, despite skin treatments,
there are certain major side-effects associated with corticosteroids,
anti-infectives, anti-acne, retinoids, and every other drug class, which are
quite prominent than others. Such side-effects have some grave negative implications
on the health and lifestyle, which could strain in the dermatological
therapeutics market.
Key geographies covered in the global dermatological
therapeutics market are:
•          North America: United States and
Canada
•          Europe: United Kingdom, France, Germany,
Spain, Italy, Russia, and Rest of Europe
•          Asia-Pacific: China, Japan, India,
Australia, South Korea, ASEAN Countries, and Rest of Asia-Pacific
•          Latin America: Brazil, Mexico, and
Rest of Latin America
•          Middle East and Africa: Saudi Arabia,
Turkey, United Arab Emirates, South Africa, and Rest of Middle East &
Africa
The segmentation analysis of the dermatological
therapeutics market includes:
•          Market by Drug Class:
OÂ Â Â Â Â Â Â Â Anti-infectives
OÂ Â Â Â Â Â Â Â Corticosteroids
OÂ Â Â Â Â Â Â Â Anti-acne
OÂ Â Â Â Â Â Â Â Calcineurin Inhibitors
OÂ Â Â Â Â Â Â Â Retinoids
OÂ Â Â Â Â Â Â Â Other Drug Classes
•          Market by Application:
OÂ Â Â Â Â Â Â Â Alopecia
OÂ Â Â Â Â Â Â Â Herpes
OÂ Â Â Â Â Â Â Â Psoriasis
OÂ Â Â Â Â Â Â Â Rosacea
OÂ Â Â Â Â Â Â Â Atopic Dermatitis
OÂ Â Â Â Â Â Â Â Acne Vulgaris
OÂ Â Â Â Â Â Â Â Other Applications
The key companies
profiled in the report include AGI Dermatics, Allergan, Abbvie Inc, Amgen Inc,
Almirall, Pfizer Inc, Johnson & Johnson, Bausch Health Companies Inc,
Glaxosmithkline Plc, Galderma, Novartis AG, Merck & Co, and Leo Pharma A/S.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. KEY
INSIGHTS
2.2.1.  ASIA-PACIFIC
IS MOST ENCOURAGING REGIONAL MARKET
2.2.2.  CHINA
IS LEADING OVERALL MARKET
2.2.3.  ADVANCEMENTS
IN BIOLOGICS
2.2.4.  ATOPIC
DERMATITIS IS ANTICIPATED TO GROW AT HIGHEST CAGR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1.  THREAT
OF NEW ENTRANTS
2.3.2.  THREAT
OF SUBSTITUTE
2.3.3.  BARGAINING
POWER OF SUPPLIERS
2.3.4.  BARGAINING
POWER OF BUYERS
2.3.5.  THREAT
OF COMPETITIVE RIVALRY
2.4. IMPACT
OF COVID-19 – DERMATOLOGICAL THERAPEUTICS
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. MARKET
DRIVERS
2.7.1.  INCREASING
BURDEN OF DERMATOLOGICAL DISEASES
2.8. MARKET
RESTRAINTS
2.8.1.  GRAVE
SIDE-EFFECTS FOR CERTAIN CLASSES OF THERAPEUTIC DRUGS
2.9. MARKET
OPPORTUNITIES
2.9.1.  RISE
IN AWARENESS LEVELS OF DISEASE ORIGIN AND PROGRESSION
2.10. MARKET
CHALLENGES
2.10.1. UNAWARENESS TOWARDS
DERMATOLOGICAL DIAGNOSIS
3. GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK - BY DRUG CLASS
3.1. ANTI-INFECTIVES
3.2. CORTICOSTEROIDS
3.3. ANTI-ACNE
3.4. CALCINEURIN
INHIBITORS
3.5. RETINOIDS
3.6. OTHER
DRUG CLASSES
4. GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK - BY APPLICATION
4.1. ALOPECIA
4.2. HERPES
4.3. PSORIASIS
4.4. ROSACEA
4.5. ATOPIC
DERMATITIS
4.6. ACNE
VULGARIS
4.7. OTHER
APPLICATIONS
5. GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET – REGIONAL OUTLOOK
5.1. NORTH
AMERICA
5.1.1.  MARKET
BY DRUG CLASS
5.1.2.  MARKET
BY APPLICATION
5.1.3.  COUNTRY
ANALYSIS
5.1.3.1. UNITED
STATES
5.1.3.2. CANADA
5.2. EUROPE
5.2.1.  MARKET
BY DRUG CLASS
5.2.2.  MARKET
BY APPLICATION
5.2.3.  COUNTRY
ANALYSIS
5.2.3.1. UNITED
KINGDOM
5.2.3.2. GERMANY
5.2.3.3. FRANCE
5.2.3.4. SPAIN
5.2.3.5. ITALY
5.2.3.6. RUSSIA
5.2.3.7. REST
OF EUROPE
5.3. ASIA-PACIFIC
5.3.1.  MARKET
BY DRUG CLASS
5.3.2.  MARKET
BY APPLICATION
5.3.3.  COUNTRY
ANALYSIS
5.3.3.1. CHINA
5.3.3.2. JAPAN
5.3.3.3. INDIA
5.3.3.4. SOUTH
KOREA
5.3.3.5. ASEAN
COUNTRIES
5.3.3.6. AUSTRALIA
& NEW ZEALAND
5.3.3.7. REST
OF ASIA-PACIFIC
5.4. LATIN
AMERICA
5.4.1.  MARKET
BY DRUG CLASS
5.4.2.  MARKET
BY APPLICATION
5.4.3.  COUNTRY
ANALYSIS
5.4.3.1. BRAZIL
5.4.3.2. MEXICO
5.4.3.3. REST
OF LATIN AMERICA
5.5. MIDDLE
EAST AND AFRICA
5.5.1.  MARKET
BY DRUG CLASS
5.5.2.  MARKET
BY APPLICATION
5.5.3.  COUNTRY
ANALYSIS
5.5.3.1. UNITED
ARAB EMIRATES
5.5.3.2. TURKEY
5.5.3.3. SAUDI
ARABIA
5.5.3.4. SOUTH
AFRICA
5.5.3.5. REST
OF MIDDLE EAST & AFRICA
6. COMPETITIVE
LANDSCAPE
6.1. ABBVIE
INC
6.2. ALLERGAN
6.3. ALMIRALL
6.4. AMGEN
INC
6.5. BAUSCH
HEALTH COMPANIES INC
6.6. GALDERMA
6.7. GLAXOSMITHKLINE
PLC
6.8. JOHNSON
& JOHNSON
6.9. NOVARTIS
AG
6.10. PFIZER
INC
6.11. AGI
DERMATICS
6.12. LEO
PHARMA A/S
6.13. MERCK
& CO
7. METHODOLOGY
& SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY GEOGRAPHY, 2019-2028 (IN $ BILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)
TABLE 5: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)
TABLE 6: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY GEOGRAPHY, 2019-2028 (IN $ BILLION)
TABLE 7: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 8: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)
TABLE 9: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)
TABLE 10: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 11: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)
TABLE 12: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)
TABLE 13: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 14: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)
TABLE 15: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)
TABLE 16: LATIN AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 17: LATIN AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)
TABLE 18: LATIN AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)
TABLE 19: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 20: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)
TABLE 21: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION
FIGURE 1: PORTER’S FIVE
FORCES ANALYSIS
FIGURE 2: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $
BILLION)
FIGURE 3: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $
BILLION)
FIGURE 4: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)
FIGURE 5: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $
BILLION)
FIGURE 6: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)
FIGURE 7: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $
BILLION)
FIGURE 8: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)
FIGURE 9: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)
FIGURE 10: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $ BILLION)
FIGURE 11: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $ BILLION)
FIGURE 12: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS 2019-2028 (IN $
BILLION)
FIGURE 13: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $ BILLION)
FIGURE 14: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $
BILLION)
FIGURE 15: GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 16: UNITED
STATES DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 17: CANADA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 18: UNITED
KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 19: GERMANY DERMATOLOGICAL
THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 20: FRANCE
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 21: SPAIN
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 22: ITALY
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 23: RUSSIA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 24: REST OF
EUROPE DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 25: CHINA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 26: JAPAN
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 27: INDIA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 28: SOUTH KOREA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 29: ASEAN
COUNTRIES DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 30: AUSTRALIA
& NEW ZEALAND DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 31: REST OF
ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 32: BRAZIL
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 33: MEXICO
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 34: REST OF
LATIN AMERICA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 35: UNITED ARAB
EMIRATES DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 36: TURKEY
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 37: SAUDI ARABIA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 38: SOUTH AFRICA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 39: REST OF
MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $
BILLION)